Vascular Disease, Alzheimer's Disease, and Mild Cognitive Impairment : Advancing an Integrated Approach

個数：

電子版価格
¥14,748

電子版あり

Vascular Disease, Alzheimer's Disease, and Mild Cognitive Impairment : Advancing an Integrated Approach

Libon, David J. (EDT)/ Lamar, Melissa (EDT)/ Swenson, Rodney A. (EDT)

ウェブストア価格 ¥27,272（本体¥24,793）
Oxford University Press Inc（2020/04発売）
外貨定価 US$ 130.00
ポイント 247pt

提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
【重要ご説明事項】
1. 納期遅延や、ご入手不能となる場合が若干ございます。
2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
3. 美品のご指定は承りかねます。

●3Dセキュア導入とクレジットカードによるお支払いについて

【入荷遅延について】
世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。

◆画像の表紙や帯等は実物とは異なる場合があります。

◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
また、洋書販売価格は、ご注文確定時点での日本円価格となります。
ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。

製本 Hardcover:ハードカバー版／ページ数 504 p.
言語 ENG
商品コード 9780190634230
DDC分類 616.8

Full Description

Alzheimer's disease (AD) and vascular dementia (VaD) are commonly viewed as the first and second most common types of dementia, respectively. The traditional paradigm has been to view and treat each illness as a separate entity with a separate pathophysiology. However, clinical and pathological studies suggest that the boundary separating AD and VaD, as well as their mild cognitive impairment (MCI) analogs, is not well defined. Thus, there is increased interest in viewing these diseases along a spectrum because of the significant overlap in the characterization and diagnosis of AD, VaD, and MCI. The focus of this edited volume is to examine how AD and VaD, as well as their MCI analogs, are best viewed as a heterogeneous, intersecting, if not a continuous disease state rather than separate, distinct entities. This book examines this approach by providing empirically based evidence, reviews of the literature, and chapters by key leaders in the field and will be of interest to clinical neuropsychologists and anyone studying or treating dementia in its many forms.

Preface

Part 1: Epidemiology and Neuropsychology

Chapter 1: Vascular risk factors and their relationship to brain aging: Findings from the Framingham Heart Study
Chapter 2: Neuropsychological Profiles in Alzheimer's/ Vascular Spectrum Dementia
Chapter 3: Neuropsychological Diagnostic Criteria for Mild Cognitive Impairment due to Alzheimer's Disease
Chapter 4: Vascular Cognitive Impairment
Chapter 5: Decline in Everyday Functioning in MCI and Dementia: A Neuropsychological Perspective
Chapter 6: Heterogeneity in Dementia and MCI: Using Statistical Modeling Techniques
Chapter 7: Apraxic and Action-Intentional Disorders Associated With Vascular And Degenerative Dementing Diseases

Part 2: Neuroimaging

Chapter 8: Cerebral small vessel disease and the risk of dementia and cognition decline
Chapter 9: Structural MRI in Alzheimer's disease: Are we measuring the right stuff
Chapter 10: Advances in Multi-Modal Imaging Across the Spectrum of Normal to Pathological aging: Incorporating Vascular Comorbidities Common to Alzheimer's disease and Vascular Dementia

Part 3: Blood-Brain-Barrier and Cardiogenic Mechanisms

Chapter 11: The Blood-Brain Barrier in Cognitive Decline and Alzheimer's Disease
Chapter 12: Arterial Stiffening and Cerebrovascular Resistance in Cognitive Decline and Alzheimer's Disease
Chapter 13: Hemodynamics in Alzheimer's Disease and Vascular Cognitive Impairment & Dementia

Part 4: Neuropathological and Neurophysiological Mechanisms

Chapter 14: Neuropathology of AD/ VaD Dementia
Chapter 15: Potential of blood- and CSF-based biomarkers for AD diagnostics
Chapter 16: Unravelling the Role of Mitochondria in Alzheimer's disease: Toward Assembling the Puzzle

Part 5: Treatment and Intervention

Chapter 17: Dementia and Elective Surgeries: Considerations for Neuropsychologists
Chapter 18: Management of Mild Cognitive Impairment